XML 20 R7.htm IDEA: XBRL DOCUMENT v3.22.2.2
CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($)
$ in Thousands
 9 Months Ended
Oct. 29, 2022
Oct. 30, 2021
CASH FLOWS FROM OPERATING ACTIVITIES:    
Net income $ 49,387 $ 148,168
Reconciliation of net income to net cash provided by (used in) operating activities:    
Non-cash portion of operating lease expense 65,046 76,418
Depreciation and amortization 39,320 44,157
Non-cash stock-based compensation expense 19,055 25,036
Deferred income tax provision 2,186 17,974
Asset impairment charges 1,379 1,254
Other non-cash items, net 58 1,101
Changes in operating assets and liabilities:    
Inventories (123,012) (55,183)
Accounts receivable and other assets (28,427) (2,121)
Prepaid expenses and other current assets 1,680 (4,995)
Income taxes payable, net of prepayments 18,896 6,437
Accounts payable and other current liabilities 11,764 (47,980)
Lease liabilities (75,767) (142,574)
Other long-term liabilities 1,470 (244)
Net cash provided by (used in) operating activities (16,965) 67,448
CASH FLOWS FROM INVESTING ACTIVITIES:    
Capital expenditures (31,193) (22,000)
Change in deferred compensation plan (421) 48
Net cash used in investing activities (31,614) (21,952)
CASH FLOWS FROM FINANCING ACTIVITIES:    
Borrowings under revolving credit facility 555,383 557,034
Repayments under revolving credit facility (465,701) (552,429)
Repayment of term loan 0 (1,000)
Purchase and retirement of common stock, including shares surrendered for tax withholdings and transaction costs (75,672) (45,187)
Payment of debt issuance costs 0 (366)
Net cash provided by (used in) financing activities 14,010 (41,948)
Effect of exchange rate changes on cash and cash equivalents (974) (34)
Net increase (decrease) in cash and cash equivalents (35,543) 3,514
Cash and cash equivalents, beginning of period 54,787 63,548
Cash and cash equivalents, end of period 19,244 67,062
OTHER CASH FLOW INFORMATION:    
Net cash paid (received) for income taxes (15,680) 31,718
Cash paid for interest 7,545 11,870
Increase (decrease) in accrued capital expenditures $ 7,795 $ (135)